Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL5730494

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Binding
cytomteric bead array (CBA) assay: The Fix buffer I was warmed up to 37° C. in an incubator or water bath prior to use. The Perm Buffer III was chilled in a â¿¿20° C. freezer prior to use. The cells were collected at the end of treatment with testing compounds. One volume of the pre-warmed Fix Buffer I was mixed with one volume of cell suspension. If the volume of the cell suspension is greater than 100 uL, the cells were spun and resuspended in 100 uL medium or PBS. The buffer and the cell suspension were mixed well and incubated in a 37° C. water bath for 10 min. The cells were spun down at 250ÿg for 10 min and the supernatant was aspirated. The cells were washed once with BD Stain Buffer. The pellet was spun and the supernatant was removed. The cells were vortexed to be loosened, and permeabilized by slowly adding cold Perm Buffer III while vortexing or mixing. Subsequently, the cells were incubated on ice for 30 min. The cells were then spun down and washed twice with Stain Buffer. The supernatant was spun and aspirated. The cells were resuspended in a small volume of Stain buffer (50 or 100 uL containing from 200,000 to 1 million cells). Anti-IKFZ3 antibody was added to the cell suspension at 1:1000 dilution and incubated for 45 min at 4° C. The cells were then spun down and washed once with stain buffer. Secondary antibody was added to the cells at 1:5000 dilution and incubated at room temperature for 20 min in the dark. The cells were washed once with stain buffer prior to analysis by FACS.
21
Total Activities
7
Compounds Tested
3
Activity Types
0
Assay Parameters

Assay Information

Assay Type Binding
Confidence 0 — Uncurated / Unknown
Curated By Autocuration

Target

Unchecked (CHEMBL612545)
Type UNCHECKED

Publication

Methods for the treatment of locally advanced breast cancer
(2017)

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
IC50 7 7.19 8.66
kon 7 - -
k_off 7 - -

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL3989927 IBERDOMIDE 3.0 3 8.66
CHEMBL5949264 3 8.04
CHEMBL5922366 3 7.41
CHEMBL3989934 AVADOMIDE 2.0 3 6.02
CHEMBL43452 POMALIDOMIDE 4.0 3 5.82
CHEMBL468 THALIDOMIDE 4.0 3 -
CHEMBL848 LENALIDOMIDE 4.0 3 -

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL3989927 IBERDOMIDE IC50 = 2.2 nM 8.66
CHEMBL5949264 IC50 = 9.2 nM 8.04
CHEMBL5922366 IC50 = 39.0 nM 7.41
CHEMBL3989934 AVADOMIDE IC50 = 950.0 nM 6.02
CHEMBL43452 POMALIDOMIDE IC50 = 1500.0 nM 5.82
CHEMBL5949264 kon = - -
CHEMBL5949264 k_off = - s-1 -
CHEMBL5922366 kon = - -
CHEMBL5922366 k_off = - s-1 -
CHEMBL3989927 IBERDOMIDE kon = - -
CHEMBL3989927 IBERDOMIDE k_off = - s-1 -
CHEMBL3989934 AVADOMIDE k_off = - s-1 -
CHEMBL468 THALIDOMIDE IC50 > 10000.0 nM -
CHEMBL468 THALIDOMIDE kon = - -
CHEMBL468 THALIDOMIDE k_off = - s-1 -
CHEMBL43452 POMALIDOMIDE kon = - -
CHEMBL43452 POMALIDOMIDE k_off = - s-1 -
CHEMBL848 LENALIDOMIDE IC50 > 10000.0 nM -
CHEMBL848 LENALIDOMIDE kon = - -
CHEMBL848 LENALIDOMIDE k_off = - s-1 -
CHEMBL3989934 AVADOMIDE kon = - -